Skip to main content
. 2000 Nov;44(11):3144–3149. doi: 10.1128/aac.44.11.3144-3149.2000

TABLE 1.

MICs of β-lactams for A. fermentans RYC-MR95, E. coli harboring recombinant plasmids which produce β-lactamase ACI-1, and reference strainsa

Antibiotic MIC (μg/ml)
RYC-MR95 RYC4093 RYC4356 RYC1000/(pJC10) RYC1000/(pJC4) RYC1000
Penicillin 128 ≤0.5 ≤0.5
Amoxicillin 64 1 ≤0.5 1,024 8 8
Amoxicillin-Cla ≤0.03 ≤0.03 ≤0.03 8 4 4
Ticarcillin 256 1 ≤0.5 ≥1,024 4 4
Ticarcillin-Cla 0.25 0.5 ≤0.03 16 4 4
Cephalothin 4 ≤0.5 ≤0.5 16 2 2
Cephalothin-Cla 2 0.5 0.25 4 2 2
Ceftazidime 32 2 2 16 0.12 0.12
Ceftazidime-Cla 2 2 0.5 0.5 0.12 0.12
Cefotaxime 64 0.5 0.5 4 0.03 0.03
Cefotaxime-Cla 0.25 0.5 0.25 0.03 0.03 0.03
Cefepime 1 0.015 0.03
Cefepime-Cla 0.015 0.03
Cefoxitin 4 1 1 1 0.5 0.5
Imipenem 0.5 0.5 0.5 0.12 0.06 0.06
a

RYC-MR95 is wild-type A. fermentans producing ACI-1. RYC4093 and RYC4356 are β-lactam-susceptible A. fermentans strains. RYC1000 harboring recombinant plasmid pJC10 produced the ACI-1 β-lactamase. RYC1000 harboring recombinant plasmid pJC4 contained a truncated aci1 gene. Cla, clavulanic acid at a fixed concentration of 2 μg/ml.